Bertil Jönsson

1.5k total citations
53 papers, 978 citations indexed

About

Bertil Jönsson is a scholar working on Mechanical Engineering, Oncology and Mechanics of Materials. According to data from OpenAlex, Bertil Jönsson has authored 53 papers receiving a total of 978 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Mechanical Engineering, 11 papers in Oncology and 9 papers in Mechanics of Materials. Recurrent topics in Bertil Jönsson's work include Welding Techniques and Residual Stresses (9 papers), Fatigue and fracture mechanics (9 papers) and Automotive and Human Injury Biomechanics (7 papers). Bertil Jönsson is often cited by papers focused on Welding Techniques and Residual Stresses (9 papers), Fatigue and fracture mechanics (9 papers) and Automotive and Human Injury Biomechanics (7 papers). Bertil Jönsson collaborates with scholars based in Sweden, Netherlands and United Kingdom. Bertil Jönsson's co-authors include Zuheir Barsoum, Gary Marquis, Francesco Pignatti, Peter Nygren, Rolf Larsson, Jonas Bergh, Barbara van Zwieten‐Boot, Rolf Larsson, Spiros Vamvakas and Jörgen Kristensen and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Clinical Cancer Research.

In The Last Decade

Bertil Jönsson

51 papers receiving 912 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bertil Jönsson Sweden 18 210 206 205 187 174 53 978
Phillip Ross United States 10 247 1.2× 37 0.2× 216 1.1× 423 2.3× 42 0.2× 16 1.5k
Yinghong Zhang China 17 68 0.3× 73 0.4× 28 0.1× 235 1.3× 29 0.2× 99 833
Guangyu Ma China 16 269 1.3× 30 0.1× 179 0.9× 137 0.7× 9 0.1× 84 1.1k
Chao Zheng China 17 15 0.1× 84 0.4× 89 0.4× 490 2.6× 30 0.2× 53 1.1k
Luca Mazzarella Italy 22 90 0.4× 22 0.1× 712 3.5× 797 4.3× 17 0.1× 90 1.8k
Qiang Yao China 15 38 0.2× 39 0.2× 37 0.2× 214 1.1× 15 0.1× 100 1.4k
In‐Gyu Kim South Korea 16 17 0.1× 18 0.1× 64 0.3× 64 0.3× 158 0.9× 78 861
Zhaohai Li United States 17 42 0.2× 15 0.1× 36 0.2× 172 0.9× 38 0.2× 74 1.0k
Krzysztof Lis Poland 9 81 0.4× 76 0.4× 23 0.1× 53 0.3× 11 0.1× 47 434
Arzu Onar United States 14 207 1.0× 32 0.2× 55 0.3× 199 1.1× 8 0.0× 25 806

Countries citing papers authored by Bertil Jönsson

Since Specialization
Citations

This map shows the geographic impact of Bertil Jönsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bertil Jönsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bertil Jönsson more than expected).

Fields of papers citing papers by Bertil Jönsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bertil Jönsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bertil Jönsson. The network helps show where Bertil Jönsson may publish in the future.

Co-authorship network of co-authors of Bertil Jönsson

This figure shows the co-authorship network connecting the top 25 collaborators of Bertil Jönsson. A scholar is included among the top collaborators of Bertil Jönsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bertil Jönsson. Bertil Jönsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bowen, Debra L., Jorge Camarero, Pierre Démolis, et al.. (2015). Early market access of cancer drugs in the EU. Annals of Oncology. 27(1). 96–105. 61 indexed citations
2.
Pignatti, Francesco, Bertil Jönsson, Gideon M. Blumenthal, & Robert Justice. (2014). Assessment of benefits and risks in development of targeted therapies for cancer — The view of regulatory authorities. Molecular Oncology. 9(5). 1034–1041. 17 indexed citations
3.
Vecchio, Stefania, Stéphanie Tellier, Heli Mustonen, et al.. (2013). Retrospective poisons centres-based study on adverse effects due to plant food supplements. Clinical Toxicology. 51(4). 267–268. 1 indexed citations
5.
Jönsson, Bertil & Jonas Bergh. (2012). Hurdles in anticancer drug development from a regulatory perspective. Nature Reviews Clinical Oncology. 9(4). 236–243. 26 indexed citations
6.
Jönsson, Bertil, et al.. (2009). Influence from weld position on fillet weld quality. Welding in the World. 55. 137–142. 3 indexed citations
7.
McCabe, Christopher, Lothar Bergmann, Nicholas Bosanquet, et al.. (2008). Market and patient access to new oncology products in Europe: a current, multidisciplinary perspective. Annals of Oncology. 20(3). 403–412. 52 indexed citations
8.
Jönsson, Bertil, Hans Stenlund, & Ulf Björnstig. (2008). Backset—Stationary and During Car Driving. Traffic Injury Prevention. 9(6). 568–573. 5 indexed citations
9.
Albertsson, Maria, Jonas Bergh, Gunnar Birgegård, et al.. (2007). Erythropoietin therapy and cancer related anaemia: updated Swedish recommendations. Medical Oncology. 24(3). 267–272. 4 indexed citations
10.
Jönsson, Bertil, et al.. (2002). 71 Scavenging system layout of a 25 cc two-stroke engine intended for stratified scavenging. SAE technical papers on CD-ROM/SAE technical paper series. 1. 3 indexed citations
11.
Lewis, John A., Bertil Jönsson, Gottfried Kreutz, Cristina Sampaio, & Barbara van Zwieten‐Boot. (2002). Placebo-controlled trials and the Declaration of Helsinki. The Lancet. 359(9314). 1337–1340. 57 indexed citations
12.
Jönsson, Bertil, et al.. (2000). Apoptosis induced by calcein acetoxymethyl ester in the human histiocytic lymphoma cell line U-937 GTB. Biochemical Pharmacology. 60(12). 1751–1759. 17 indexed citations
13.
Jönsson, E., Sumeer Dhar, Bertil Jönsson, et al.. (2000). Differential activity of topotecan, irinotecan and SN-38 in fresh human tumour cells but not in cell lines. European Journal of Cancer. 36(16). 2120–2127. 27 indexed citations
14.
Jönsson, Bertil, et al.. (1999). On the mechanism underlying calcein-induced cytotoxicity. European Journal of Pharmacology. 383(3). 321–329. 12 indexed citations
15.
Jönsson, Bertil. (1998). Circumventing drug resistance : studies exploring the expediency of a total cell kill chemoresistance assay. 1 indexed citations
16.
Jönsson, Bertil, K Csóka, H Fridborg, et al.. (1996). Cytotoxic activity of calcein acetoxymethyl ester (calcein/AM) on primary cultures of human haematological and solid tumours. European Journal of Cancer. 32(5). 883–887. 35 indexed citations
17.
Nygren, Peter, K Csóka, Bertil Jönsson, et al.. (1995). The cytotoxic activity of Taxol in primary cultures of tumour cells from patients is partly mediated by Cremophor EL. British Journal of Cancer. 71(3). 478–481. 43 indexed citations
18.
Kristensen, Jörgen, Bertil Jönsson, Christer Sundström, Peter Nygren, & Rolf Larsson. (1992). In vitro analysis of drug resistance in tumor cells from patients with acute myelocytic leukemia. Medical Oncology and Tumor Pharmacotherapy. 9(2). 65–74. 10 indexed citations
19.
Larsson, Rolf, et al.. (1992). Selective cytotoxic activity of cyclosporins against tumor cells from patients with B cell chronic lymphocytic leukemia. European Journal of Pharmacology Environmental Toxicology and Pharmacology. 228(4). 237–240. 8 indexed citations
20.
Jönsson, Bertil, et al.. (1992). SDZ PSC-833—a novel potent in vitro chemosensitizer in multiple myeloma. Anti-Cancer Drugs. 3(6). 641–646. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026